PARP1 and ovarian carcinoma: Because of these promising results, including the rapid in vivo clearance and high contrast imaging in mouse models, we anticipate that 68 Ga-DOTA-Olaparib may be a promising radiotracer for monitoring ovarian cancer tissues with elevated PARP expression and detecting abdominal tumor metastases.